Lataa...
FLT3 mutated acute myeloid leukemia: 2021 treatment algorithm
Approximately 30% of patients with newly diagnosed acute myeloid leukemia (AML) harbor mutations in the fms-like tyrosine kinase 3 (FLT3) gene. While the adverse prognostic impact of FLT3-ITD(mut) in AML has been clearly proven, the prognostic significance of FLT3-TKD(mut) remains speculative. Curre...
Tallennettuna:
| Julkaisussa: | Blood Cancer J |
|---|---|
| Päätekijät: | , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Nature Publishing Group UK
2021
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8159924/ https://ncbi.nlm.nih.gov/pubmed/34045454 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41408-021-00495-3 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|